FDA Does Not Rule that IQOS Reduces Tobacco-Related Harm

Mythbuster: Learn how PMI is spinning the truth to further their unfounded claims.

In July 2020, the U.S. Food and Drug Administration (FDA) approved IQOS, a heated tobacco product, as a “modified risk tobacco product. Though the FDA agreed that the data submitted by Philip Morris International (PMI) showed that IQOS may reduce exposure to harmful substances, they conceded that IQOS does not reduce risk of disease and death when compared to cigarette smoking. Nevertheless, PMI has hailed the decision as a “milestone for public healtha blatant misrepresentation of the FDA’s decision.  

Read more, including PMI’s own admission that IQOS is not proven to be a healthier alternative. 

Read the brief in Spanish

Read More